BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-7642

  1. 3,814 Posts.
    lightbulb Created with Sketch. 408
    Looking at closer to $3 per share being conservative with projected SOFDRA sales and clinical stage pipeline.
    Not advice, using Euroz and Japan numbers.
    Last edited by asx11: 08/03/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.